spacer Johns Hopkins University spacer spacer
Site Index Hopkins Medicine Other Hopkins Websites Directions
Division of Clinical Pharmacology
Home Overview Faculty Training Drug Development Unit Analytical Labs Hospital Pharmacologist Seminars Links
spacer Meet Our Faculty
spacer spacer
Andrea Meyerhoff, MD MSc DTMH spacer
Andrea Meyerhoff, MD MSc DTMH
Adjunct Associate Professor

Johns Hopkins University
Osler 527
600 N. Wolfe Street
Baltimore, MD 21287
Phone: 410-502-3252
Fax: 410-614-9978


Research Interests:
Drugs for tropical diseases; drug development and policy for medical countermeasures for biodefense; clinical trial design

Selected Publications:
Meyerhoff A. (1999) The FDA approval of AmBisome for the treatment of visceral leishmaniasis. Clin Infect Dis. 28:42-8.

Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes J, Jahrling P, Ksiazek T, Johnson K, Meyerhoff A, O'Toole T, Ascher MS, Bartlett J, Breman JG, Eitzen EM Jr, Hamburg M, Hauer J, Henderson DA, Johnson RT, Kwik G, Layton M, Lillibridge S, Nabel GJ, Osterholm MT, Perl TM, Russell P, Tonat K. (2002) Hemorrhagic fever viruses as biological weapons. JAMA 287: 2391-406.

Meyerhoff A, Albrecht R, Meyer J, Dionne P, Higgins K, Murphy D. (2004) The FDA approval of Cipro for post-exposure inhalational anthrax. Clin Infect Dis. 39:303-8.

Meyerhoff A. Challenges in drug development: Biological agents of intentional use In: New Drug Applications: Regulatory and Scientific Principles for Clinical Pharmacology and Biopharmaceutics, Sahajwalla, C, ed. Marcel Dekker, 2004.

Meyerhoff A, Lietman P. All the World’s a Laboratory. Op-ed, New York Times. May 20, 2009, p. A23.

Meyerhoff A. Challenges to CBRN medical countermeasures development In: Wiley Handbook of Science and Technology for Homeland Security, Voeller, J, ed. John Wiley & Sons, 2009.

Return to Faculty Home